Literature DB >> 23868145

Obesity-related glomerulopathy and the nephron complement.

Nobuo Tsuboi1, Yasunori Utsunomiya, Tatsuo Hosoya.   

Abstract

Obesity-related glomerulopathy (ORG) is a secondary form of glomerular disease that can occur in individuals with obesity. However, the absolute risk for an obese individual to develop progressive renal deterioration is low. Therefore, obesity alone appears to be insufficient to develop such severe renal injury, and there are likely other factors that contribute to the development of this entity. The glomerular hyperfiltration found in patients with ORG has been postulated to lead to structural abnormalities in glomeruli, such as glomerulomegaly and focal segmental glomerular sclerosis, in a manner analogous to that described in patients with reduced renal mass. In fact, recent studies suggest that a reduction in nephron mass is implicated in patients with ORG and synergistically contributes to the development of this renal complication together with obesity-induced changes in renal hemodynamics.

Entities:  

Keywords:  glomerular density; glomerulomegaly; hyperfiltration; nephron number; obesity

Mesh:

Year:  2013        PMID: 23868145     DOI: 10.1093/ndt/gft258

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  23 in total

1.  Nephron hypertrophy and glomerulosclerosis in normal donor kidneys.

Authors:  Wendy E Hoy; John F Bertram; Michael D Hughson
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-15       Impact factor: 8.237

Review 2.  Structural and Functional Changes in Human Kidneys with Healthy Aging.

Authors:  Musab S Hommos; Richard J Glassock; Andrew D Rule
Journal:  J Am Soc Nephrol       Date:  2017-08-08       Impact factor: 10.121

3.  Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice.

Authors:  Ping Yang; Yayun Xiao; Xuan Luo; Yunfei Zhao; Lei Zhao; Yan Wang; Tingting Wu; Li Wei; Yaxi Chen
Journal:  J Lipid Res       Date:  2017-05-23       Impact factor: 5.922

4.  Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.

Authors:  Aaron J Polichnowski; Hector Licea-Vargas; Maria Picken; Jianrui Long; Rashmi Bisla; Geoffrey A Williamson; Anil K Bidani; Karen A Griffin
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-24

Review 5.  Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity.

Authors:  Alejandro R Chade; John E Hall
Journal:  Am J Nephrol       Date:  2016-10-22       Impact factor: 3.754

6.  Cafeteria diet-fed mice is a pertinent model of obesity-induced organ damage: a potential role of inflammation.

Authors:  Nadine Zeeni; Carole Dagher-Hamalian; Hani Dimassi; Wissam H Faour
Journal:  Inflamm Res       Date:  2015-05-13       Impact factor: 4.575

7.  Developmental cigarette smoke exposure II: Kidney proteome profile alterations in 6 month old adult offspring.

Authors:  Rachel E Neal; Rekha Jagadapillai; Jing Chen; Cynthia L Webb; Kendall Stocke; Cailtin Gambrell; Robert M Greene; M Michele Pisano
Journal:  Reprod Toxicol       Date:  2016-05-18       Impact factor: 3.143

Review 8.  Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease.

Authors:  Giorgina B Piccoli; Giorgio Grassi; Gianfranca Cabiddu; Marta Nazha; Simona Roggero; Irene Capizzi; Agostino De Pascale; Adriano M Priola; Cristina Di Vico; Stefania Maxia; Valentina Loi; Anna M Asunis; Antonello Pani; Andrea Veltri
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 9.  Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.

Authors:  Merlin C Thomas; Mark E Cooper; Paul Zimmet
Journal:  Nat Rev Nephrol       Date:  2015-11-10       Impact factor: 28.314

10.  Association of Obesity with Cardiovascular Risk Factors and Kidney Disease Outcomes in Primary Proteinuric Glomerulopathies.

Authors:  Paras P Shah; Tammy M Brady; Kevin E C Meyers; Michelle M O'Shaughnessy; Keisha L Gibson; Tarak Srivastava; Jarcy Zee; Daniel Cattran; Katherine R Tuttle; Crystal Gadegbeku; Dorey Glenn; Vimal Derebail; Abigail Smith; Chia-Shi Wang; Brenda W Gillespie; Markus Bitzer; Christine B Sethna
Journal:  Nephron       Date:  2021-03-05       Impact factor: 2.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.